Literature DB >> 33893489

Household Exposure to Severe Acute Respiratory Syndrome Coronavirus 2 and Association With Coronavirus Disease 2019 Severity: A Danish Nationwide Cohort Study.

Marcella Broccia1,2, Victoria Elizabeth de Knegt3, Elisabeth Helen Anna Mills4, Amalie Lykkemark Møller2, Filip Gnesin2, Thea K Fischer5, Nertila Zylyftari2, Stig Nikolaj Blomberg6, Mikkel Porsborg Andersen2, Morten Schou7, Emil Fosbøl8, Kristian Kragholm7,9, Helle Collatz Christensen10, Laura Bech Polcwiartek11, Matthew Phelps12, Lars Køber9, Christian Torp-Pedersen2,4.   

Abstract

BACKGROUND: Households are high-risk settings for the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severity of coronavirus disease 2019 (COVID-19) is likely associated with the infectious dose of SARS-CoV-2 exposure. We therefore aimed to assess the association between SARS-CoV-2 exposure within households and COVID-19 severity.
METHODS: We performed a Danish, nationwide, register-based, cohort study including laboratory-confirmed SARS-CoV-2-infected individuals from 22 February 2020 to 6 October 2020. Household exposure to SARS-CoV-2 was defined as having 1 individual test positive for SARS-CoV-2 within the household. Cox proportional hazards models were used to estimate the association between "critical COVID-19" within and between households with and without secondary cases.
RESULTS: From 15 063 multiperson households, 19 773 SARS-CoV-2-positive individuals were included; 11 632 were categorized as index cases without any secondary household cases; 3431 as index cases with secondary cases, that is, 22.8% of multiperson households; and 4710 as secondary cases. Critical COVID-19 occurred in 2.9% of index cases living with no secondary cases, 4.9% of index cases with secondary cases, and 1.3% of secondary cases. The adjusted hazard ratio for critical COVID-19 among index cases vs secondary cases within the same household was 2.50 (95% confidence interval [CI], 1.88-3.34), 2.27 (95% CI, 1.77-2.93) for index cases in households with no secondary cases vs secondary cases, and 1.1 (95% CI, .93-1.30) for index cases with secondary cases vs index cases without secondary cases.
CONCLUSIONS: We found no increased hazard ratio of critical COVID-19 among household members of infected SARS-CoV-2 index cases.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  corona; death; infectious dose; transmission; viral load

Mesh:

Year:  2022        PMID: 33893489      PMCID: PMC8135460          DOI: 10.1093/cid/ciab340

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

1.  Investigate the interaction of testosterone/progesterone with ionic liquids on varying the anion to combat COVID-19: Density functional theory calculations and molecular docking approach.

Authors:  Kamlesh Kumari; Ajay Kumar; Indra Bahadur; Prashant Singh
Journal:  J Phys Org Chem       Date:  2021-08-18       Impact factor: 2.155

2.  Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.

Authors:  Ekaterini Simões Goudouris; Fernanda Pinto-Mariz; Leonardo Oliveira Mendonça; Carolina Sanchez Aranda; Rafaela Rolla Guimarães; Cristina Kokron; Myrthes Toledo Barros; Flávia Anísio; Maria Luiza Oliva Alonso; Fernanda Marcelino; Solange Oliveira Rodrigues Valle; Sergio Dortas Junior; Irma Douglas Paes Barreto; Janáira Fernandes Severo Ferreira; Pérsio Roxo-Junior; Almerinda Maria do Rego Silva; Fernanda Lugão Campinhos; Carmem Bonfim; Gisele Loth; Juliana Folloni Fernandes; Julia Lopes Garcia; Albertina Capelo; Olga Akiko Takano; Maria Isabel Valdomir Nadaf; Eliana C Toledo; Luciana Araújo Oliveira Cunha; Regina Sumiko Watanabe Di Gesu; Laire Schidlowski; Priscila Fillipo; Daniélli C Bichuetti-Silva; Gustavo Soldateli; Natasha Rebouças Ferraroni; Ellen de Oliveira Dantas; Simone Pestana; Eli Mansour; Raisa Gusso Ulaf; Carolina Prando; Antonio Condino-Neto; Anete Sevciovic Grumach
Journal:  J Clin Immunol       Date:  2021-06-23       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.